2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
By T. Anderson, J. Grégoire, G. Pearson, A. Barry, P. Couture, M. Dawes, G. Francis, J. Genest, S. Grover, M. Gupta and 12 more. Canadian Journal of Cardiology, 2016
860 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics, Surgery
View Paper: https://www.semanticscholar.org/paper/3f7eae0b9435801b6ab2e8bfce1a43ef8fed4d0e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Economics and Econometrics
In Surgery
Citations in the corpus
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. (2021, background): “John Mancini MD , Priya Manjoo MD , Ruth McPherson MD, PhD , Daniel Ngui MD , Marie-Eve Piché MD, PhD , Paul Poirier MD, PhD , John Sievenpiper MD, PhD , James Stone MD, PhD , Rick Ward MD , Wendy Wray RN, MScN , 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for ”
- A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. (2017, background): “The 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia consider Lp(a) >30 mg/dl to be a risk factor, and suggest measuring Lp(a) to inform decision-making, particularly in patients at intermediate risk and those with a family history of premature CAD, and in younger p”